ETF Managers Group LLC increased its position in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 308.9% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 172,386 shares of the company’s stock after acquiring an additional 130,225 shares during the period. ETF Managers […]
ETF Managers Group LLC raised its stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 308.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 172,386 shares of the company’s stock after purchasing an additional 130,225 shares during the quarter. ETF […]
Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Krystal Biotech (NASDAQ:KRYS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Volatility & Risk Adaptive Biotechnologies has a beta of 1.18, […]
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) CFO Tycho Peterson sold 38,000 shares of Adaptive Biotechnologies stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $7.16, for a total transaction of $272,080.00. Following the completion of the transaction, the chief financial officer now directly owns 454,891 shares […]
Platinum Investment Management Ltd. lifted its holdings in shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Rating) by 39.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 366,230 shares of the company’s stock after buying an additional 102,739 shares during the quarter. […]